Private company

Dana–Farber Cancer Institute

Logo: dana-farber.org4

Cancer treatment and research institution in Boston, US

Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts. Dana–Farber is the founding member of the Dana–Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and is a principal teaching affiliate and research institute of Harvard Medical School. As of 2024, Dana–Farber is ranked as the sixth-best cancer hospital in the US.2 Its revenue was $3.5 billion in 2024.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1947Founded1
  • Industryhospitals and rehabilitation, research1
  • HeadquartersBoston, United States1
  • Websitewww.dana-farber.org
  • Legal form501(c)(3) organization1
  • Kind of organizationNonprofit organization1
  • LEI549300CLSX1WQ2279M823
  • StatusActive3
  • LEI statusLapsed (not renewed)3
  • Registered address450 Brookline Avenue, 02215 Boston, United States3
  • Registered withCorporations Division (Secretary of the Commonwealth's Office), 0422630403
Dana–Farber Cancer Institute (54954487999)
Photo: ajay_suresh, CC BY 4.0, via Wikimedia Commons6

Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts. Dana–Farber is the founding member of the Dana–Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and is a principal teaching affiliate and research institute of Harvard Medical School.2

Corporate structure

Dana–Farber Cancer Institute sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Dana–Farber Cancer Institute Boston, Massachusetts, United States
    • DANA-FARBER, INC. Subsidiary · Boston, Massachusetts, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0). Each entity in the chart links to its source.

The story

In 1947, pediatric pathologist Sidney Farber founded the Children's Cancer Research Foundation (CCRF) with Variety Club to raise money for cancer research. The foundation launched the Jimmy Fund the following year with an advertising campaign featuring a child nicknamed "Jimmy", and constructed the Jimmy Fund Building in the Longwood Medical Area in 1952 to house research facilities. In 1969, the foundation expanded its programs to include patients of all ages, and in 1974 was renamed the Sidney Farber Cancer Center.

In 1962, philanthropist Charles A. Dana, through the Dana Foundation, began financial support of the CCRF. The Dana Building was opened near the Jimmy Fund building in 1975, and in 1983, the organization's name was changed to Dana–Farber Cancer Institute in recognition of the foundation's support.

In 1997, the Smith Research Laboratories building was opened across the street from the Dana Building and the inpatient hospital was moved to Brigham and Women's Hospital, freeing up space for research, laboratories, and adult outpatient care. The Yawkey Center for Cancer Care was opened adjacent to the Smith Laboratories in 2011 to provide additional outpatient facilities.

In September 2023, Dana–Farber Cancer Institute announced a new partnership with Beth Israel Deaconess Medical Center and plans to build a new standalone inpatient hospital focused on treating adult cancer patients. This includes a departure from their current home and longtime affiliation with Brigham and Women's Hospital, which had been recognized among U.S. News & World Report's top cancer care facilities for 23 consecutive years.

From Wikipedia’s article on Dana–Farber Cancer Institute, shared under CC BY-SA 4.0.5

Leadership

Who has led Dana–Farber Cancer Institute, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (1)

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

Dana–Farber Cancer Institute revenue by year1$3.5B in 2024+189% since 2015
0$1.0B$2.0B$3.0B$4.0B2015: $1.2B$1.2B20152016: $1.4B$1.4B2016+14%2017: $1.5B$1.5B2017+9%2018: $1.8B$1.8B2018+17%2019: $2.0B$2.0B2019+13%2020: $2.0B$2.0B2020+1%2021: $2.4B$2.4B2021+21%2022: $2.7B$2.7B2022+10%2023: $3.4B$3.4B2023+27%2024: $3.5B$3.5B2024+2%
  • 2024$3.5B1
  • 2023$3.4B1
  • 2022$2.7B1
  • 2021$2.4B1
  • 2020$2.0B1
  • 2019$2.0B1

Timeline

  1. 1947Founded Founded1

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$3.0B 2008–2026
Figures by year
YearFederal grantsOther federal assistanceFederal contractsTotal
2026$184.0M$3.4M$933.0K$188.4M
2025$175.7M$2.3M–$178.0M
2024$175.8M$1.6M–$177.3M
2023$191.4M$916.5K–$192.4M
2022$163.8M–$49.0K$163.8M
2021$180.5M–$88.3K$180.6M
2020$186.2M–$261.6K$186.5M
2019$175.1M–$62.8K$175.2M
2018$185.7M––$185.7M
2017$151.0M––$151.0M
2016$136.0M–$20.3K$136.0M
2015$136.9M–$40.0K$137.0M
2014$135.9M–$309.3K$136.2M
2013$114.2M–$25.5K$114.2M
2012$145.2M––$145.2M
2011$131.0M–$118.0K$131.1M
2010$175.3M–$7.8K$175.3M
2009$152.2M––$152.2M
2008$89.6M–$33.1K$89.7M

Federal awards

Obligated amounts from USAspending.gov7, by calendar year, 2008–2026, for its registration. Obligations are what agencies committed, not always what was paid out. Contracts pay for goods and services; grants, loans and direct payments are assistance. Loans are charted at the face value of the loans listed here. An award’s amount below is its lifetime total, and some began before the years charted.

Largest grants

  1. Dec 1, 1977$235.8M from National Institutes of Health: Trans-Nih Research Support; 21St Century Cures Act - Beau Biden Cancer Moonshot; Cancer Centers Support Grants; Trans-Nih Recovery Act Research Support8 To DANA-FARBER CANCER INSTITUTE, INC. Award P30CA006516
  2. Apr 29, 2014$101.9M from National Institutes of Health: Cancer Treatment Research9 To DANA-FARBER CANCER INSTITUTE, INC. Award U10CA180794
  3. Apr 25, 1997$36.9M from National Institutes of Health: Cancer Treatment Research10 To DANA-FARBER CANCER INSTITUTE, INC. Award P01CA066996
  4. Sep 16, 2003$33.2M from National Institutes of Health: Cancer Centers Support Grants; Trans-Nih Recovery Act Research Support11 To DANA-FARBER CANCER INSTITUTE, INC. Award P50CA100707
  5. Aug 31, 2007$30.9M from National Institutes of Health: Cancer Centers Support Grants12 To DANA-FARBER CANCER INSTITUTE, INC. Award P50CA127003
  6. Sep 1, 2011$30.1M from National Institutes of Health: 21St Century Cures Act - Beau Biden Cancer Moonshot; Cancer Treatment Research13 To DANA-FARBER CANCER INSTITUTE, INC. Award P01CA155258
  7. Sep 30, 2018$29.1M from National Institutes of Health: 21St Century Cures Act - Beau Biden Cancer Moonshot; Cancer Detection And Diagnosis Research14 To DANA-FARBER CANCER INSTITUTE, INC. Award U24CA233243
  8. Jun 20, 2007$28.4M from National Institutes of Health: Human Genome Research15 To DANA-FARBER CANCER INSTITUTE, INC. Award P50HG004233

Largest direct payments

  1. May 1, 2024$4.5M from National Institutes of Health: Cancer Cause And Prevention Research16 To DANA-FARBER CANCER INSTITUTE, INC. Award OT2CA297572
  2. Sep 26, 2023$2.3M from National Institutes of Health: Cancer Cause And Prevention Research17 To DANA-FARBER CANCER INSTITUTE, INC. Award OT2CA291436
  3. May 1, 2026$1.4M from National Institutes of Health: Cancer Cause And Prevention Research18 To DANA-FARBER CANCER INSTITUTE, INC. Award OT2CA319961

Largest contracts

  1. Sep 30, 2026$933.0K from Food and Drug Administration: Firm fixed price award baa fy2600123: a multiomics approach to improving the identification of the side effects of immune checkpoint inhibit19 To DANA-FARBER CANCER INSTITUTE, INC. Award 75F40126C00068
  2. Jun 20, 2014$279.4K from National Institutes of Health: Igf::ot::igf ambis # 1674851 testing20 To DANA-FARBER CANCER INSTITUTE, INC. Award HHSN272201400641P
  3. Mar 31, 2021$167.8K from Department of Veterans Affairs: Improving palliative measurement (impacs) study21 To DANA-FARBER CANCER INSTITUTE, INC. Award 36C26121P0710
  4. Oct 1, 2011$74.4K from Federal Prison System / Bureau of Prisons: For outpatient medical services for inmate weitzman, lawrence 12645-023 during a cancer clinical trial study(cal-101). fy201222 To DANA-FARBER CANCER INSTITUTE, INC. Award DJBP0205LB270001
  5. Aug 14, 2020$70.7K from Department of Veterans Affairs: Improving palliative measurement application with computer-assisted- abstraction study (impacs)23 To DANA-FARBER CANCER INSTITUTE, INC. Award 36C26120P1370

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23